Hits and misses in treating diabetic complications: part I

Abstract

There have been few outright success stories regarding new treatments for diabetic complications over the past few years, but much can be learnt from both the hits and the misses, said Dr David Tomlinson from the University of London, UK, at the 2nd International Conference on ‘Diabetic Complications as Drug Targets’ [ London, UK; May 1996 ]. A number of potential treatments for diabetic complications were reviewed at the meeting, which was organised by William Harvey Research Conferences. In this week’s issue, Inpharma ® looks at the progress and the pitfalls seen with the aldose reductase inhibitors and glycosylation antagonists. Other agents will be featured next week.